CardioMEMS Pulmonary Artery Pressure Guided Management of Advanced HF Patients Supported with a HeartMate LVAD: INTELLECT 2-HF Study

Thohan, Vinay; Abraham, Jacob; Burdorf, A.; Farrar, David J.; Dirckx, Nicholas; Baker, A.; Drakos, Stavros

doi:10.1016/j.healun.2021.01.1962

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An approach that could potentially guide the hemodynamic optimization of LVAD-supported patients is the use of a pulmonary artery implantable monitor device to serially assess the hemodynamic status of patients on MCS [ 86 ]. Such an approach is currently under investigation in the INTELLECT-2 trial which recently announced very promising results (Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™ (Abbott Laboratories, Chicago, IL, USA); NCT03247829) trial [ 87 ].…”

Section: Current and Future Opportunities For Improvementmentioning

confidence: 99%

LVAD as a Bridge to Remission from Advanced Heart Failure: Current Data and Opportunities for Improvement

Kyriakopoulos

Kapelios

Stauder

et al. 2022

JCM

View full text Add to dashboard Cite

Left ventricular assist devices (LVADs) are an established treatment modality for advanced heart failure (HF). It has been shown that through volume and pressure unloading they can lead to significant functional and structural cardiac improvement, allowing LVAD support withdrawal in a subset of patients. In the first part of this review, we discuss the historical background, current evidence on the incidence and assessment of LVAD-mediated cardiac recovery, and out-comes including quality of life after LVAD support withdrawal. In the second part, we discuss current and future opportunities to promote LVAD-mediated reverse remodeling and improve our pathophysiological understanding of HF and recovery for the benefit of the greater HF population.

show abstract

Section: Current and Future Opportunities For Improvementmentioning

confidence: 99%